KLK3 and posterior cortical atrophy: Despite the fact that PCa screening based on PSA has been associated with a decrease in PCa-related mortality, overdiagnosis, and overtreatment of silent PCa, 20%–30% of patients were diagnosed with high-risk localized and locally advanced PCa (1, 19).